Charles River Laboratories (CRL)
Cash conversion cycle
Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
---|---|---|---|---|---|---|
Days of inventory on hand (DOH) | days | 77.23 | 144.22 | 112.87 | 95.73 | 102.25 |
Days of sales outstanding (DSO) | days | 63.86 | 69.76 | 67.01 | 68.66 | 76.70 |
Number of days of payables | days | 38.91 | 64.07 | 90.86 | 95.24 | 67.44 |
Cash conversion cycle | days | 102.18 | 149.91 | 89.03 | 69.15 | 111.52 |
December 31, 2024 calculation
Cash conversion cycle = DOH + DSO – Number of days of payables
= 77.23 + 63.86 – 38.91
= 102.18
The cash conversion cycle of Charles River Laboratories has fluctuated over the past five years. In December 2020, the cash conversion cycle was 111.52 days, indicating that it took the company approximately 111.52 days to convert its investments in inventory and accounts receivable into cash from sales.
Over the following years, there were variations in the cash conversion cycle. By the end of December 2021, the cycle decreased to 69.15 days, suggesting an improvement in the efficiency of the company's cash management. However, there was a slight increase in the cycle by the end of December 2022, reaching 89.03 days.
In December 2023, there was a significant increase in the cash conversion cycle, jumping to 149.91 days, which may indicate potential challenges in managing inventory levels or collecting receivables efficiently. However, in December 2024, the cycle decreased to 102.18 days, reflecting some improvement from the previous year.
Overall, Charles River Laboratories should continue to monitor and manage its cash conversion cycle effectively to ensure optimal working capital management and overall financial health.
Peer comparison
Dec 31, 2024